In vitro study in stimulating the secretion of angiogenic growth factors of strontium-doped calcium polyphosphate for bone tissue engineering
- 447 Downloads
- 21 Citations
Abstract
Angiogenesis of tissue-engineered bone remains a limited factor for the engineering of larger bone tissue constructs. Attempts to stimulate angiogenesis, using recombinant protein or gene transfer of angiogenic growth factors, have been proposed; however, these approaches have been associated with some problems regarding such as complex technique, expensive prices as well as safety problems and short half-life of angiogenic growth factors. This study was performed to determine the ability of strontium-doped calcium polyphosphate (SCPP) to induce angiogenesis via researching its effect on the mRNA expressions and protein secretion of VEGF and bFGF in/from cultured osteoblasts (ROS17/2.8 cells). We cultured osteoblasts with SCPP scaffolds containing various doses of strontium as well as calcium polyphosphate (CPP) scaffold. Through the detection of MTT and SEM, we have found that SCPP could promote cell proliferation and maintain their morphology. The results of RT–PCR and ELISA indicated that, compared with those in CPP group, the mRNA expression as well as protein levels of VEGF and bFGF in/from cultured osteoblasts were dose-dependent increasing in response to increasing strontium before reaching the peak in SCPP groups, and 8% SCPP showed the optimal promoting role. Therefore, SCPP containing proper dose of strontium could be served as a potential biomaterial with stimulating angiogenesis in bone tissue engineering and bone repair.
Keywords
Vascular Endothelial Growth Factor Strontium Strontium Ranelate Bone Tissue Engineering Angiogenic Growth FactorNotes
Acknowledgments
This work was supported by the National Natural Science Foundation of China (30870616), Basic Research Program of Sichuan Province-China (07JY029-075) and Natural Science Foundation of Jiangsu Province-China (BK2008152). We would like to thank the Analysis and Testing Center, Sichuan University (China) for their assistance of the completion of scanning electron microscopy analysis.
References
- 1.Kanczler JM, Oreffo RO. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater. 2008;15:100–14.Google Scholar
- 2.Davies N, Dobner S, Bezuidenhout D, Schmidt C, Beck M, Zisch AH, Zilla P. The dosage dependance of VEGF stimulation on scaffold neovascularisation. Biomaterials. 2008;29:3531–8.CrossRefGoogle Scholar
- 3.Muschler GF, Nakamoto C, Griffith LG. Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am. 2004;86:1541–58.Google Scholar
- 4.Jabbarzadeh E, Starnes T, Khan YM, Jiang T, Wirtel AJ, Deng M, Lv Q, Nair LS, Doty SB, Laurencin CT. Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: a combined gene therapy-cell transplantation approach. Proc Natl Acad Sci USA. 2008;105:11099–104.CrossRefGoogle Scholar
- 5.Bussolino F, Mantovani A, Persico G. Molecular mechanisms of blood vessel formation. Trends Biochem Sci. 1997;22:251–6.CrossRefGoogle Scholar
- 6.Tong JP, Yao YF. Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions. Clin Biochem. 2006;39:267–76.CrossRefGoogle Scholar
- 7.Phillips HS, Hains J, Leung DW, Ferrara N. Vascular endothelial growth factor is expressed in rat corpus luteum. Endocrinology. 1990;127:965–7.CrossRefGoogle Scholar
- 8.Koos RD. Increased expression of vascular endothelial growth/permeability factor in the rat ovary following an ovulatory gonadotropin stimulus: potential roles in follicle rupture. Biol Reprod. 1995;52:1426–35.CrossRefGoogle Scholar
- 9.Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med. 1999;77:527–43.CrossRefGoogle Scholar
- 10.Canalis E, Centrella M, McCarthy T. Effects of basic fibroblast growth factor on bone formation in vitro. J Clin Invest. 1988;81:1572–7.CrossRefGoogle Scholar
- 11.Hurley MM, Abreu C, Harrison JR, Lichtler AC, Raisz LG, Kream BE. Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells. J Biol Chem. 1993;268:5588–93.Google Scholar
- 12.Seghezzi G, Patel S, Ren CJ. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Bio1. 1998;141:1659–73.CrossRefGoogle Scholar
- 13.Tokuda H, Hirade K, Wang X. Involvement of SAPK/JNK in basic fibroblast growth factor-induced vascular endothelial growth factor release in osteoblasts. J Endocrino1. 2003;177:101–7.CrossRefGoogle Scholar
- 14.Fuchsa S, Mottab A, Migliaresi C. Outgrowth endothelial cells isolated and expanded from human peripheral blood progenitor cells as a potential source of autologous cells for endothelialization of silk fibroin biomaterials. Biomaterials. 2006;27:5399–408.CrossRefGoogle Scholar
- 15.Richardson TO, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual growth factor delivery. Nat Biotechnol. 2001;19:1029–34.CrossRefGoogle Scholar
- 16.Perets A, Baruch Y, Weisbuch F, Shoshany G, Neufeld G, Cohen S. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mat Res. 2003;65A:485–97.Google Scholar
- 17.Nomi M, Atala A, Coppi PD, Soker S. Principals of neovascularization for tissue engineering. Mol Aspects Med. 2002;23:463–83.Google Scholar
- 18.Jang JH, Rives CB, Shea LD. Plasmid delivery in vivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection. Mol Ther. 2005;12:475–83.CrossRefGoogle Scholar
- 19.Huang YC, Kaigler D, Rice KG, Krebsbach PH, Mooney DJ. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res. 2005;20:848–57.CrossRefGoogle Scholar
- 20.Perets A, Baruch Y, Weisbuch F, Shoshany G, Neufeld G, Cohen S. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res A. 2003;65:489–97.CrossRefGoogle Scholar
- 21.Marie PJ. Strontium ranelate: a novel mode of action optimizing bone formation and resorption. Osteoporos Int. 2005;16:S7–10.CrossRefGoogle Scholar
- 22.Ammann P. Strontium ranelate: a novel mode of action leading to renewed bone quality. Osteoporos Int. 2005;16:S11–5.CrossRefGoogle Scholar
- 23.Nielsen SP. The biological role of strontium. Bone. 2004;35:583–8.CrossRefGoogle Scholar
- 24.Canalis E, et al. The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone. 1996;18:517–23.CrossRefGoogle Scholar
- 25.Qiu K, Zhao XJ, Wan CX. Effect of strontium ions on the growth of ROS17/2.8 cells on porous calcium polyphosphate scaffolds. Biomaterials. 2006;27:1277–86.CrossRefGoogle Scholar
- 26.Tian M, Chen F, Song W. In vivo study of porous strontium-doped calcium polyphosphate scaffolds for bone substitute applications. J Mater Sci Mater Med. 2009;20:1505–12.CrossRefGoogle Scholar
- 27.Chen YW, Feng T, Shi GQ. Interaction of endothelial cells with biodegradable strontium-doped calcium polyphosphate for bone tissue engineering. Appl Surf Sci. 2008;255:331–5.CrossRefGoogle Scholar
- 28.Chen YW, Shi GQ, Ding YL. In vitro study on the influence of strontium-doped calcium polyphosphate on the angiogenesis-related behaviors of HUVECs. J Mater Sci Mater Med. 2008;19:2655–62.CrossRefGoogle Scholar
- 29.Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–8.CrossRefGoogle Scholar
- 30.Brown EM. Is the calcium receptor a molecular target for the actions of strontium on bone? Osteoporos Int. 2003;14:S25–34.Google Scholar
- 31.Coulonbe J, Faure H, Robin B, Ruat M. In vitro effects of strontium ranelate on the extraccllular calcium sensing receptor. Biochem Biophys Res Commun. 2004;323:1184–90.CrossRefGoogle Scholar
- 32.Verberckmoes SC, DeBroe ME, D’Haese PC. Dose-dependent effects of strontium on osteoblast function and mineralisation. Kidney Int. 2003;64:534–43.CrossRefGoogle Scholar
- 33.Maehata Y, Takamizawa S, Ozawa S. Both direct and collagen-mediated signals are required for active vitamin D3-elicited differentiation of human osteoblastic cells: roles of osterix, an osteoblast-related transcription factor. Matrix Biol. 2006;25:47–58.CrossRefGoogle Scholar
- 34.Zhu Y, Gao C, Guan J, Shen J. Promoting the cytocompatibility of polyurethane scaffolds via surface photo-grafting polymerization of acrylamide. J Mater Sci Mater Med. 2004;15:283–9.CrossRefGoogle Scholar
- 35.Ronald EU, Sartoris A, Peters K. Tissue-like self-assembly in cocultures of endothelial cells and osteoblasts and the formation of microcapillary-like structures on three-dimensional porous biomaterials. Biomaterials. 2007;28:3965–76.CrossRefGoogle Scholar
- 36.Choudhary S, Wadhwa S, Raisz LG, Alander C, Pilbeam CC. Extracellular calcium is a potent inducer of cyclo-oxygenase-2 in murine osteoblasts through an ERK signaling pathway. J Bone Miner Res. 2003;18:1813–24.CrossRefGoogle Scholar
- 37.Street J, Bao M. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA. 2002;999:656–61.Google Scholar
- 38.Young MF, Kerr JM, Ibaraki K. Structure, expression, and regulation of the major noncollagenous matrix proteins of bone. Clin Orthop. 1992;281:275–94.Google Scholar